Abstract
Bcr gene was originally identified by its presence in the chimeric Bcr/Ab1 oncogene. In vascular smooth muscle cells, platelet-derived growth factor-BB (PDGF) stimulated Bcr kinase activity. The mutant PDGF receptor for PI3-K, but not for PLC-γ binding sites, showed significantly reduced Bcr kinase activity. Bcr wild-type enhanced, whereas Bcr kinase negative form inhibited PDGF-stimulated ERK1/2 activity. A dominant negative Ras did not inhibit Bcr kinase activation, and overexpression of Bcr increased Ras/Raf-1 activity and DNA synthesis. These results demonstrated the importance of Bcr in PDGF-mediated events such as activation of Ras, Raf-1, and ERK1/2 and stimulation of DNA synthesis.
Original language | English (US) |
---|---|
Pages (from-to) | 341-343 |
Number of pages | 3 |
Journal | Annals of the New York Academy of Sciences |
Volume | 947 |
DOIs | |
State | Published - 2001 |
Keywords
- Bcr
- ERK1/2
- Platelet-derived growth factor: PDGF
- Raf-1
- Ras
- Vascular smooth muscle cells
ASJC Scopus subject areas
- General Neuroscience
- General Biochemistry, Genetics and Molecular Biology
- History and Philosophy of Science